Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1987 Jun;55(6):1498–1502. doi: 10.1128/iai.55.6.1498-1502.1987

Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrier.

M E Jolivet, F M Audibert, H Gras-Masse, A L Tartar, D H Schlesinger, R Wirtz, L A Chedid
PMCID: PMC260542  PMID: 3553005

Abstract

Four synthetic peptides that copy fragments of two bacterial antigens (Streptococcus pyogenes M protein and diphtheria toxin), one viral antigen (hepatitis B surface antigen), and one parasitic antigen (circumsporozoite protein of Plasmodium knowlesi) were covalently bound within the same construct. This totally synthetic polyvalent administered to mice with Freund complete adjuvant or in saline with murabutide (an adjuvant-active muramyl peptide) elicited high levels of antibodies which, in certain cases, were shown to be biologically active. The results indicated that these antibodies recognized specifically the four peptides. None of the epitopes were immunodominant. It was also demonstrated that the association of several peptides enhanced their respective immunogenicities as compared with those of their homopolymers. Finally, this study shows that a totally synthetic vaccine administered in saline with a synthetic adjuvant can be immunogenic in the absence of a protein carrier.

Full text

PDF
1498

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Audibert F. M., Przewlocki G., Leclerc C. D., Jolivet M. E., Gras-Masse H. S., Tartar A. L., Chedid L. A. Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens. Infect Immun. 1984 Jul;45(1):261–266. doi: 10.1128/iai.45.1.261-266.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Audibert F., Jolivet M., Chedid L., Alouf J. E., Boquet P., Rivaille P., Siffert O. Active antitoxic immunization by a diphtheria toxin synthetic oligopeptide. Nature. 1981 Feb 12;289(5798):593–594. doi: 10.1038/289593a0. [DOI] [PubMed] [Google Scholar]
  3. Audibert F., Jolivet M., Chedid L., Arnon R., Sela M. Successful immunization with a totally synthetic diphtheria vaccine. Proc Natl Acad Sci U S A. 1982 Aug;79(16):5042–5046. doi: 10.1073/pnas.79.16.5042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beachey E. H., Seyer J. M., Dale J. B., Simpson W. A., Kang A. H. Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature. 1981 Jul 30;292(5822):457–459. doi: 10.1038/292457a0. [DOI] [PubMed] [Google Scholar]
  5. Beachey E. H., Seyer J. M., Kang A. H. Primary structure of protective antigens of type 24 streptococcal M protein. J Biol Chem. 1980 Jul 10;255(13):6284–6289. [PubMed] [Google Scholar]
  6. Benjamin D. C., Berzofsky J. A., East I. J., Gurd F. R., Hannum C., Leach S. J., Margoliash E., Michael J. G., Miller A., Prager E. M. The antigenic structure of proteins: a reappraisal. Annu Rev Immunol. 1984;2:67–101. doi: 10.1146/annurev.iy.02.040184.000435. [DOI] [PubMed] [Google Scholar]
  7. Chedid L., Jolivet M., Audibert F., Przewlocki G., Beachey E. H., Gras-Masse H., Tartar A. Antibody responses elicited by a polyvalent vaccine containing synthetic diphtheric, streptococcal and hepatitis peptides coupled to the same carrier. Biochem Biophys Res Commun. 1983 Dec 28;117(3):908–915. doi: 10.1016/0006-291x(83)91682-0. [DOI] [PubMed] [Google Scholar]
  8. Clough E. R., Audibert F. M., Barnwell J. W., Schlesinger D. H., Arnon R., Chedid L. A. Biologically active antibodies elicited by a synthetic circumsporozoite peptide of Plasmodium knowlesi administered in saline with a muramyl dipeptide derivative. Infect Immun. 1985 Jun;48(3):839–842. doi: 10.1128/iai.48.3.839-842.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Clough E. R., Jolivet M., Audibert F., Barnwell J. W., Schlesinger D. H., Chedid L. Production of anti-sporozoite antibodies in absence of response to carrier by coupling an MDP derivative to a malaria peptide-tetanus toxoid conjugate. Biochem Biophys Res Commun. 1985 Aug 30;131(1):70–76. doi: 10.1016/0006-291x(85)91771-1. [DOI] [PubMed] [Google Scholar]
  10. Cochrane A. H., Santoro F., Nussenzweig V., Gwadz R. W., Nussenzweig R. S. Monoclonal antibodies identify the protective antigens of sporozoites of Plasmodium knowlesi. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5651–5655. doi: 10.1073/pnas.79.18.5651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Godson G. N., Ellis J., Svec P., Schlesinger D. H., Nussenzweig V. Identification and chemical synthesis of a tandemly repeated immunogenic region of Plasmodium knowlesi circumsporozoite protein. Nature. 1983 Sep 1;305(5929):29–33. doi: 10.1038/305029a0. [DOI] [PubMed] [Google Scholar]
  12. Gras-Masse H. S., Jolivet M. E., Audibert F. M., Beachey E. H., Chedid L. A., Tartar A. L. Influence of CONH2 or COOH as C-terminus groups on the antigenic characters of immunogenic peptides. Mol Immunol. 1986 Dec;23(12):1391–1395. doi: 10.1016/0161-5890(86)90025-8. [DOI] [PubMed] [Google Scholar]
  13. Gysin J., Barnwell J., Schlesinger D. H., Nussenzweig V., Nussenzweig R. S. Neutralization of the infectivity of sporozoites of Plasmodium knowlesi by antibodies to a synthetic peptide. J Exp Med. 1984 Sep 1;160(3):935–940. doi: 10.1084/jem.160.3.935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jolivet M., Audibert F., Beachey E. H., Tartar A., Gras-Masse H., Chedid L. Epitope specific immunity elicited by a synthetic streptococcal antigen without carrier or adjuvant. Biochem Biophys Res Commun. 1983 Dec 16;117(2):359–366. doi: 10.1016/0006-291x(83)91208-1. [DOI] [PubMed] [Google Scholar]
  15. Lefrancier P., Derrien M., Jamet X., Choay J., Lederer E., Audibert F., Parant M., Parant F., Chedid L. Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides. J Med Chem. 1982 Jan;25(1):87–90. doi: 10.1021/jm00343a018. [DOI] [PubMed] [Google Scholar]
  16. Schlesinger D. H., Cochrane A. H., Gwadz R. W., Godson G. N., Melton R., Nussenzweig R. S., Nussenzweig V. Structure of an immunodominant epitope of the circumsporozoite surface protein of Plasmodium knowlesi. Biochemistry. 1984 Nov 6;23(23):5665–5670. doi: 10.1021/bi00318a043. [DOI] [PubMed] [Google Scholar]
  17. Telzak E., Wolff S. M., Dinarello C. A., Conlon T., el Kholy A., Bahr G. M., Choay J. P., Morin A., Chedid L. Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccine. J Infect Dis. 1986 Mar;153(3):628–633. doi: 10.1093/infdis/153.3.628. [DOI] [PubMed] [Google Scholar]
  18. Vanderberg J., Nussenzweig R., Most H. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. V. In vitro effects of immune serum on sporozoites. Mil Med. 1969 Sep;134(10):1183–1190. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES